Ethical Issues in Living-Related Corneal Tissue Transplantation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Euro GTP Guidance
EUROGTP Euro GTP Guidance European Union Project in the framework of the Public Health Program Agreement number: 2007 207 Coordinator: Transplant Services Foundation 1 List of Authors ‐ Euro GTP Project Coordinator TSF ▪ Transplant Services Foundation | Spain Project Partners BISLIFE | Netherlands BTV ▪ Banca Tessuti della Regione Veneto | Italy CBC ▪ Hornhautbank Berlin Charite Universitatsmedizin | Germany EHB ▪ European Homograft Bank | Belgium ESB ▪ Euro Skin Bank | Netherlands HBM ▪ Hornhautbank München Gemeinnutzige | Germany ISS‐CNT ▪ Istituto Superiore di Sanita Centro Nazionale Trapianti | Italy KCBTiK ▪ Krajowe Centrum Bankowania Tkanek I Komórek | Poland QAMH ▪ Queen Astrid Military Hospital | Belgium REGEA ▪ Tampere Yliopisto. University of Tampere | Finland i Table of Contents PURPOSE AND SCOPE ................................................................................................................................................1 SECTION A: GENERAL REQUIREMENTS .......................................................................................................................3 A.1. PERSONNEL ............................................................................................................................................................... 3 A.2. FACILITIES AND EQUIPMENT ..................................................................................................................................... 8 A.2.1. FACILITIES, EQUIPMENT AND MATERIALS FOR RECOVERY............................................................................... -
Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges
E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST SCIENCE PUBLISHERS Lengerich Bibliographic information published by Die Deutsche Nationalbibliothek Die Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data is available in the Internet at <http://dnb.ddb.de>. This work is subject to copyright. All rights are reserved, whether the whole or part of the mate- rial is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a spe- cific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The authors and the publisher of this volume have taken care that the information and recommen- dations contained herein are accurate and compatible with the standards generally accepted at the time of publication. Nevertheless, it is difficult to ensure that all the information given is entirely accurate for all circumstances. The publisher disclaims any liability, loss, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this volume. © 2017 Pabst Science Publishers · D-49525 Lengerich Internet: www.pabst-publishers.de, www.pabst-science-publishers.com E-mail: [email protected] Print: ISBN 978-3-95853-292-2 eBook: ISBN 978-3-95853-293-9 (www.ciando.com) Formatting: µ Printed in Germany by KM-Druck, D-64823 Gross-Umstadt Contents Preface Introduction Emma K. -
Freezing of Surplus Donated Whole Eyes in the Central Eye Bank of Iran
RESEARCH Freezing of Surplus Donated Whole Eyes in the Central Eye Bank of Iran Use of Defrosted Corneas for Deep Anterior Lamellar Keratoplasty and Report of Postoperative Eye Bank Data Mozhgan Rezaei Kanavi, MD; Mohammad Ali Javadi, MD; Fatemeh Javadi; Tahereh Chamani, MS ABSTRACT especially when a shortage exists for fresh donor corneas for transplantation. PURPOSE: To describe the method of freezing and thaw- KEYWORDS: cornea, freezing, whole eyes, DALK, ing of donated whole eyes (DWEs), which were surplus to eye banks, thawing....................................... requirements in the Central Eye Bank of Iran (CEBI), and to report the 3-year results of using defrosted corneas in deep anterior lamellar keratoplasty (DALK) in keratoconic eyes. he Central Eye Bank of Iran (CEBI) is the METHODS: The method of freezing and thawing of only eye bank in Iran and is located in Tehran. surplus DWEs in the CEBI is described. Surplus DWEs Tissue requirements for corneal and scleral at the CEBI were disinfected, processed, and transferred T transplantation in Iran are supplied and preserved to the freezer (-70°C) for long-term preservation. In case 1 of a shortage of fresh and refrigerated corneas for DALK, by the CEBI. There has been an increasing trend in a frozen DWE was defrosted and distributed for trans- corneal transplantation in Iran, from 200 grafts in plantation either as a whole eye in moist chamber or as 1988 to 6,053 in 2012 (unpublished data). Keratoco- an excised corneoscleral disc in Eusol C at 2˚C to 8˚C. nus is the most common indication for penetrating Furthermore, eye bank data of the frozen DWEs as well 1 as postoperative eye bank reports of implementation of keratoplasty in Iran, accounting for 34.5% of cases. -
Four Cases of Corneal Perforation in Patients with Chronic Graft- Versus-Host Disease
Molecular Vision 2011; 17:598-606 <http://www.molvis.org/molvis/v17/a68> © 2011 Molecular Vision Received 21 October 2010 | Accepted 15 February 2011 | Published 25 February 2011 Four cases of corneal perforation in patients with chronic graft- versus-host disease Emi Inagaki, Yoko Ogawa, Yukihiro Matsumoto, Tetsuya Kawakita, Shigeto Shimmura, Kazuo Tsubota Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan Purpose: To report the clinical features and investigate the underlying pathological processes of spontaneous corneal perforation in patients with ocular chronic graft-versus-host disease (cGVHD). Methods: A full ophthalmological evaluation of corneal perforation in four patients with cGVHD was performed. Three of them underwent deep anterior lamellar keratoplasty and samples from two of three patients were used for histopathological analyses. Results: Three patients were successfully treated by corneal transplantation. One patient was treated with a therapeutic soft contact lens, and the wound healed within 2 days. The common clinical features of these patients were (1) the presence of definite dry eye related to cGVHD in 3 of 4 patients and probable dry eye in one patient, (2) a central or paracentral site of corneal ulceration and perforation, with no sign of infection, and (3) prior use of a topical or systemic corticosteroid, and/or topical non-steroidal anti-inflammatory drugs. Immunohistochemical findings revealed an increased number of cluster of differentiation 68+ (CD68+) macrophages and matrix metalloproteinase 9 (MMP-9) expression in the tissue surrounding the perforation. Conclusions: Our report extends current information on the clinical features and pathological processes of corneal perforation in cGVHD by showing increased MMP-9 expression and the accumulation of CD68+ positive macrophages in the affected areas. -
Fast Facts & Stats
FAST FACTS & STATS “Of all the senses, sight must be the most delightful.” ~ Helen Keller More sensory neurons are dedicated to vision than the other four senses combined, and giving the gift of sight – through cornea donation – can be life-giving and life-changing. But what does it really mean? “Eye donation” doesn’t mean the entire eye is transplanted; instead, only the cornea (the clear, dome-shaped surface that covers the front of the eye) is replaced, restoring sight for those with cornea-related blindness. The entire eye can be used for research and education, potentially helping untold thousands of people regain their sight as researchers gain new understanding of the cause and effects of eye conditions that lead to blindness. Historical facts: · The first human corneal transplant was performed in 1905 by Dr. Eduard Zirm in Olomouc, Czechoslovakia. · The first U.S. transplant was performed in New York City by Dr. R. Townley Paton in 1937. · The first eye bank – a non-profit organization that recovers, evaluates, prepares and distributes eyes donated for use in corneal transplantation, research and education – opened in 1944 in New York City. · The Eye Bank Association of America, established in 1961, is the oldest transplant association and was formed by a group of ophthalmologists and eye bankers. Statistics: · 50,930: Number of corneas provided for transplant in the U.S. in 2017, meeting 100% of U.S. demand. · 33,367: Number of corneas exported, helping restore sight worldwide. · 12 million: Corneal disease cases worldwide that result in blindness or visual impairment— and that could be reversed with cornea transplants. -
Surgically Induced Scleral Staphyloma
Original Article Surgically induced scleral staphyloma Yong Yao1, Ming-Zhi Zhang1, Vishal Jhanji1,2 1Joint International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China; 2Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China Contributions: (I) Conception and design: Y Yao; (II) Administrative support: MZ Zhang; (III) Provision of study materials or patients: Y Yao; (IV) Collection and assembly of data: Y Yao; (V) Data analysis and interpretation: Y Yao; V Jhanji; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Yong Yao. Shantou International Eye Center, Jinping District, Guangxia New Town, Shantou 515041, China. Email: [email protected] or [email protected]. Background: To report the clinical features of surgically induced scleral staphyloma and investigate the management. Methods: Retrospective uncontrolled study. Results: A full ophthalmological evaluation of surgically induced scleral staphyloma in four patients was performed. The first patient was a 3-year-old young girl underwent corneal dermoid resection. The second patient was a 60-year-old man underwent nasal pterygium excision and conjunctival autograft without Mitomycin C (MMC). The other two were respectively a 74-year-old woman and a 69-year-old man underwent cataract surgery. All patients performed allogeneic sclera patch graft. In the at least half a year follow-up, the best corrected visual acuity (BCVA) of all the four patients were no worse than that of preoperative. Ocular symptoms disappeared, including eye pain, foreign body sensation, and so on. Unfortunately, the fourth patient showed sclera rejection and partial dissolution at postoperative 1 month. -
Long-Term Ocular Surface Stability in Conjunctival Limbal Autograft Donor Eyes
CLINICAL SCIENCE Long-Term Ocular Surface Stability in Conjunctival Limbal Autograft Donor Eyes Albert Y. Cheung, MD,*† Enrica Sarnicola, MD,*†‡ and Edward J. Holland, MD*† (OSST) procedures can provide healthy limbal stem cells Purpose: fi – To investigate the incidence of limbal stem cell de ciency and conjunctiva to rehabilitate a damaged ocular surface.2 8 (LSCD) in donor eyes after conjunctival limbal autograft (CLAU). Conjunctival limbal autograft (CLAU) is a technique that ; Methods: An observational retrospective review was performed on transplants a portion (typically 3to6clockhours)ofthe all patients who underwent CLAU alone, combined keratolimbal healthy stem cells from an unaffected eye to the contralat- allograft with CLAU (“Modified Cincinnati Procedure”), or com- eral affected eye in individuals affected by unilateral LSCD.6 bined living-related conjunctival limbal allograft (lr-CLAL) with 7 $ Cultivated limbal epithelial transplantation (CLET) CLAU having 6 months of follow-up after surgery. The outcome 8 measures were best-corrected visual acuity (BCVA) and ocular and simple limbal epithelial transplantation (SLET) provide surface status. ex vivo and in vivo expansion of stem cells, respectively, to repopulate the ocular surface. In contrast to CLET and SLET, Results: The inclusion criteria were fulfilled by 45 patients. Of CLAU is ideal for rehabilitating severe unilateral LSCD these, 26 patients underwent CLAU, 18 underwent combined requiring combined conjunctival limbal transplantation and keratolimbal allograft/CLAU, and 1 underwent combined lr- for reconstruction of the ocular surface. Proponents of CLET CLAL/CLAU. Mean age at the time of surgery was 39.6 years. and SLET have raised concerns regarding the potential Mean logMAR preoperative BCVA was 20.08. -
Exploring Vigilance Notification for Organs
NOTIFY - E xploring V igilanc E n otification for o rgans , t issu E s and c E lls NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation e 10,00 Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 Cover Bologna, piazza del Nettuno (photo © giulianax – Fotolia.com) © Testi Centro Nazionale Trapianti © 2011 EDITRICE COMPOSITORI Via Stalingrado 97/2 - 40128 Bologna Tel. 051/3540111 - Fax 051/327877 [email protected] www.editricecompositori.it ISBN 978-88-7794-758-1 Index Part A Bologna Consultation Report ............................................................................................................................................7 Part B Working Group Didactic Papers ......................................................................................................................................57 (i) The Transmission of Infections ..........................................................................................................................59 (ii) The Transmission of Malignancies ....................................................................................................................79 (iii) Adverse Outcomes Associated with Characteristics, Handling and Clinical Errors -
Managing Ocular Surface Inflammation”
E Y 7th EDITION OLOGIES OF THE E OLOGIES OF th H 7 AT EDITION P THEA INTERNATIONAL CONTEST OF CLINICAL CASES IN PATHOLOGIES OF THE EYE THEA INTERNATIONAL CONTEST OF CLINICAL CASES IN PATHOLOGIES OF THE EYE NTEST OF CLINICAL CASES IN OF CLINICAL NTEST O This brochure is produced under the sole responsibility of the authors. Laboratoires Théa are not involved in the writing of this document. This brochure may contain MA off-label and/or not validated by health authorities information. NATIONAL C NATIONAL R HEA INTE HEA T 2018 - 2019 EDITION 2018 - 2019 EDITION MANAGING MANAGING OCULAR SURFACE OCULAR SURFACE INFLAMMATION THE BEST CLINICAL CASES FROM 22 COUNTRIES INFLAMMATION THE BEST CLINICAL CASES FROM 22 COUNTRIES WWW.THEA-TROPHY.COM CLINICAL CASES CLINICAL - BA WTROBRO0120 WWW.THEA-TROPHY.COM Laboratoires Théa • 12, rue Louis Blériot 63017 Clermont-Ferrand Cedex 2 • France T +33 4 73 98 14 36 Laboratoires Théa F +33 4 73 98 14 38 LABORATOIRES-THEA.COM th 7 EDITION This brochure is produced under the sole responsibility of the authors, Laboratoires Théa are not involved in the writing of the clinical cases. This brochure may contain MA off-label and/or not validated by health authorities information. PREFACE Mr. JEAN-FRÉDÉRIC CHIBRET TROPHY 2018-2019 the Clinical Cases 2 M. Jean-Frédéric CHIBRET President of Laboratoires Théa Théa has focused its activities on research, development and commercialization of eye-care products, but at the same time has invested in education and knowledge promotion in line with the strong Chibret family tradition. In this way, Théa supports many projects and educational activities such as the European Meeting of Young Ophthalmologists (EMYO) or its partnership with the European Board of Ophthalmology (EBO). -
Xenotransplantation: Past, Present, and Future
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Curr Opin Manuscript Author Organ Transplant Manuscript Author . Author manuscript; available in PMC 2018 December 01. Published in final edited form as: Curr Opin Organ Transplant. 2017 December ; 22(6): 513–521. doi:10.1097/MOT.0000000000000463. XENOTRANSPLANTATION: PAST, PRESENT, AND FUTURE Burcin Ekser, MD, PhD1, Ping Li, PhD1, and David K.C. Cooper, MD, PhD2 1Division of Transplant Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA 2Xenotransplantation Program, Department of Surgery, The University of Alabama at Birmingham, Birmingham, AL, USA Abstract Purpose of review—To review the progress in the field of xenotransplantation with special attention to most recent encouraging findings which will eventually bring xenotransplantation to the clinic in the near future. Recent findings—Starting from early 2000, with the introduction of Gal-knockout pigs, prolonged survival especially in heart and kidney xenotransplantation was recorded. However, remaining antibody barriers to nonGal antigens continue to be the hurdle to overcome. The production of genetically-engineered pigs was difficult requiring prolonged time. However, advances in gene editing, such as zinc finger nucleases, transcription activator-like effector nucleases, and most recently CRISPR technology made the production of genetically-engineered pigs easier and available to more researchers. Today, the survival of pig-to-nonhuman primate heterotopic heart, kidney, and islet xenotransplantation reached >900 days, >400 days, and >600 day, respectively. The availability of multiple-gene pigs (5 or 6 genetic modifications) and/or newer costimulation blockade agents significantly contributed to this success. Now, the field is getting ready for clinical trials with an international consensus. -
History of Corneal Transplantation, Eye Banking and the EBAA The
History of Corneal Transplantation, Eye Banking and the EBAA The Success of Early Corneal Transplants In 1905, when Eduard Konrad Zirm, MD, performed the first successful corneal transplant, a long line of corneal transplantation, research and techniques began. During its existence, Zirm’s eye bank, located in a rural area of Austria, treated over 47,000 patients. Not many years later in 1914, Anton Elschnig, MD, also of Austria, performed the second successful corneal transplant and over the next two decades, he would make various contributions to the study of peri-operative infection and pre-operative preparation. The 1920s and 1930s would find Russian ophthalmologist Vladimir Filatov refining lamellar keratoplasty and developing a new method for full thickness keratoplasty. He also used a donor cornea from a cadaver for a penetrating keratoplasty in the 1930s. Ramon Castroviejo, a Spanish ophthalmologist, was an influential figure in both European and American developments in corneal transplantation, particularly from the 1920s through the 1940s. During his research fellowship at the Mayo Clinic, he developed a double-bladed knife for square grafts and conducted research that culminated in the development of new keratoplasty techniques. The Beginnings of Eye Banking and the EBAA The 1940s not only brought improvements to corneal transplantation, but also an incentive to mainstream those procedures into eye banking. R. Townley Paton, a renowned American ophthalmologist who was trained at Johns Hopkins in Baltimore, had established his own practice and had become affiliated with Manhattan Eye, Ear & Throat Hospital, where he began performing corneal transplants with privately-acquired tissue. After performing many corneal transplants, Paton came to the conclusion that a formal system of eye collection needed to be developed – thus, the eye bank was born. -
Amniotic Membrane Grafts in Pediatric Corneal Limbal Dermoids with Conjunctival Eyelashes: a Case Presentation
Open Journal of Ophthalmology, 2016, 6, 191-197 http://www.scirp.org/journal/ojoph ISSN Online: 2165-7416 ISSN Print: 2165-7408 Amniotic Membrane Grafts in Pediatric Corneal Limbal Dermoids with Conjunctival Eyelashes: A Case Presentation Larisa Akah Che1, Linda A. Morgan2, Donny W. Suh2,3 1University of Nebraska Medical Center, Omaha, NE, USA 2Children’s Hospital & Medical Center, Omaha, NE, USA 3Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA How to cite this paper: Che, L.A., Morgan, Abstract L.A. and Suh, D.W. (2016) Amniotic Mem- brane Grafts in Pediatric Corneal Limbal Purpose: To report a case of a pediatric corneal limbal dermoid with eyelashes and Dermoids with Conjunctival Eyelashes: A to describe post-operative changes after excision with reconstruction using amniotic Case Presentation. Open Journal of Oph- membrane grafting, sutures and fibrinogen-thrombin glue. Case Report: One pedia- thalmology, 6, 191-197. http://dx.doi.org/10.4236/ojoph.2016.64027 tric patient was identified with a grade II infratemporal corneal-limbal dermoid with conjunctival eyelashes. The dermoid was surgically excised and the cornea recon- Received: August 23, 2016 structed with amniotic membrane using sutures and fibrinogen/thrombin glue. Pre- Accepted: October 11, 2016 operative and postoperative measurement of astigmatism, anisometropia and pres- Published: October 14, 2016 ence of exposure keratopathy were performed. Copyright © 2016 by authors and Scientific Research Publishing Inc. Keywords This work is licensed under the Creative Commons Attribution International Corneal Limbal Dermoid, Amniotic Membrane Graft, Choriostoma License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access 1.